A 70-year-old male with peripheral neuropathy, ataxia and antigliadin antibodies shows improvement in neuropathy, but not ataxia, after intravenous immunoglobulin and gluten-free diet

Journal of Multidisciplinary Healthcare

Volumn 1, Issue , 2008, Pages 93-96

  Anandacoomaraswamy, Dharshan ^a   Ullal, Jagdeesh ^b   Vinik, Aaron I ^b  

^a Maimonides Medical Center   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Autoimmune disease; Celiac disease; Cerebellar ataxia; Peripheral neuropathy; Type 2 diabetes

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; DIHOMO GAMMA LINOLENIC ACID; GLIADIN ANTIBODY; HEMOGLOBIN A1C; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IRBESARTAN; ORAL ANTIDIABETIC AGENT; PROTEIN ANTIBODY; RETICULIN ANTIBODY; THIOCTIC ACID; UNCLASSIFIED DRUG;

AGED; ANKLE; ARTICLE; ATAXIC GAIT; CASE REPORT; CELIAC DISEASE; CEREBELLAR ATAXIA; CEREBELLUM ATROPHY; CLINICAL ARTICLE; DIABETIC DIET; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG ERUPTION; ELECTROMYOGRAPHY; ERECTILE DYSFUNCTION; FAMILY HISTORY; GLUTEN FREE DIET; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; IMMUNOTOXICITY; INTESTINE BIOPSY; KINESIOTHERAPY; MALE; MUSCLE ATROPHY; N1E-115 CELL LINE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NERVE FUNCTION; NEUROBLASTOMA CELL; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PERONEUS NERVE; QUADRICEPS FEMORIS MUSCLE; RASH; SURAL NERVE; TIBIAL NERVE; TREMOR; ULNAR NERVE; UNSTEADINESS; VIBRATION SENSE;

EID: 84892600653     PISSN: None     EISSN: 11782390     Source Type: Journal    
DOI: 10.2147/JMDH.S3018     Document Type: Article

References (27)

1. Aktay AN, Lee PC, Kumar V, et al. 2001. The prevalence and clinical characteristics of celiac disease in juvenile diabetes in Wisconsin. J Pediatr Gastroenterol Nutr, 33:462–5.
2. Battisti C, Dotti MT, Formichi P, et al. 1996. Disappearance of skin lipo-fuscin storage and marked clinical improvement in adult onset coeliac disease and severe vitamin E deficiency after chronic vitamin E mega-therapy. J Submicrosc Cytol Pathol, 28:339–44.
3. Bushara KO. 2005. Neurologic presentation of celiac disease. Gastroen-terology, 128:S92–S97.
4. Bushara KO, Goebel SU, Shill H, et al. 2001. Gluten sensitivity in sporadic and hereditary cerebellar ataxia. Ann Neurol, 49:540–3.
5. Chin RL, Latov N. 2005. Peripheral neuropathy and celiac disease. Curr Treat Options Neurol, 7:43–8.
6. Chin RL, Sander HW, Brannagan TH, et al. 2003. Celiac neuropathy. Neurology, 60:1581–5.
7. Dyck PJ, Karnes JL, O’Brien PC, et al. 1992. The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity. Neurology, 42:1164–70.
8. Dyck PJ, Kratz KM, Karnes JL, et al. 1993. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology, 43:817–24.
9. Granberg V, Ejskjaer N, Peakman M, et al. 2005. Autoantibodies to autonomic nerves associated with cardiac and peripheral autonomic neuropathy. Diabetes Care, 28:1959–64.
10. Hadjivassiliou M, Gibson A, Davies-Jones GA, et al. 1996. Does cryptic gluten sensitivity play a part in neurological illness? Lancet, 347:369–71.
11. Hadjivassiliou M, Grunewald RA, Chattopadhyay AK, et al. 1998. Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet, 352:1582–5.
12. Hagen EM, Gjerde IO, Vedeler C, et al. 2000. [Neurological diseases associated with celiac disease]. Tidsskr Nor Laegeforen, 120:439–42.
13. Honnorat J, Saiz A, Giometto B, et al. 2001. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol, 58:225–30.
14. Iwasaki H, Sato R, Shichiri M, et al. 2001. A patient with type 1 diabetes mellitus and cerebellar ataxia associated with high titer of circulating anti-glutamic acid decarboxylase antibodies. Endocr J, 48:261–8.
15. Koller H, Kieseier BC, Jander S, et al. 2005. Chronic inflammatory demyelinating polyneuropathy. N Engl J Med, 352:1343–56.
16. Lang B, Dale RC, Vincent A. 2003. New autoantibody mediated disorders of the central nervous system. Curr Opin Neurol, 16:351–7.
17. Leffler D, Saha S, Farrell RJ. 2003. Celiac disease. Am J Manag Care, 9:825–31.
18. Luostarinen L, Pirttila T, Collin P. 1999. Coeliac disease presenting with neurological disorders. Eur Neurol, 42:132–5.
19. Pereira AC, Edwards MJ, Buttery PC, et al. 2004. Choreic syndrome and coeliac disease: a hitherto unrecognized association. Mov Disord, 19:478–82.
20. Pittenger GL, Liu D, Vinik AI. 1997. The apoptotic death of neuroblastoma cells caused by serum from patients with insulin-dependent diabetes and neuropathy may be Fas-mediated. J Neuroimmunol, 76:153–60.
21. Sanchez JC, Cabrera-Rode E, Sorell L, et al. 2007. Celiac disease associated antibodies in persons with latent autoimmune diabetes of adult and type 2 diabetes. Autoimmunity, 40:103–7.
22. Sharma KR, Cross J, Farronay O, et al. 2002. Demyelinating neuropathy in diabetes mellitus. Arch Neurol, 59:758–65.
23. Vinik A, Ullal J, Parson HK, et al. 2006. Diabetic neuropathies: clinical manifestations and current treatment options. Nat Clin Pract Endocrinol Metab, 2:269–81.
24. Vinik AI, Anandacoomaraswamy D, Ullal J. 2005a. Antibodies to neuronal structures: innocent bystanders or neurotoxins? Diabetes Care, 28:2067–72.
25. Vinik AI, Erbas T. 2001. Recognizing and treating diabetic autonomic neuropathy. Cleve Clin J Med, 68:928–44.
26. Vinik AI, Suwanwalaikorn S, Stansberry KB, et al. 1995. Quantitative measurement of cutaneous perception in diabetic neuropathy. Muscle Nerve, 18:574–84.
27. Vinik EJ, Hayes RP, Oglesby A, et al. 2005b. The development and validation of the Norfolk QOL-DN, a new measure of patients’ perception of the effects of diabetes and diabetic neuropathy. Diabetes Technol Ther, 7:497–508.